D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 84 Citations 26,433 404 World Ranking 9995 National Ranking 5275

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

His scientific interests lie mostly in Surgery, Internal medicine, Clinical trial, Oncology and Glioma. The Surgery study which covers Lymphoma that intersects with Biopsy and Transplantation. His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.

His Clinical trial research incorporates elements of Randomized controlled trial, Quality of life, Response assessment and Intensive care medicine. His study in Oncology is interdisciplinary in nature, drawing from both Magnetic resonance imaging and Chemotherapy. His research in Glioma intersects with topics in Cell growth, Cancer stem cell, Stem cell, Immunology and Cell cycle.

His most cited work include:

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma (1837 citations)
  • A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (1528 citations)
  • microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes (489 citations)

What are the main themes of his work throughout his whole career to date?

David Schiff mainly focuses on Internal medicine, Oncology, Surgery, Glioma and Cancer research. Internal medicine is a component of his Temozolomide, Bevacizumab, Radiation therapy, Chemotherapy and Clinical trial studies. David Schiff has researched Clinical trial in several fields, including Randomized controlled trial and Intensive care medicine.

His research on Oncology also deals with topics like

  • Clinical endpoint which intersects with area such as Adverse effect,
  • Pharmacology, which have a strong connection to Toxicity. His studies link Gastroenterology with Surgery. His study looks at the relationship between Cancer research and topics such as Pathology, which overlap with Central nervous system and Cancer.

He most often published in these fields:

  • Internal medicine (43.41%)
  • Oncology (32.48%)
  • Surgery (21.22%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (43.41%)
  • Oncology (32.48%)
  • Glioblastoma (10.61%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Oncology, Glioblastoma, Radiation therapy and Temozolomide. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Glioma. His work investigates the relationship between Glioma and topics such as Brain tumor that intersect with problems in Quality of life.

His research integrates issues of Cancer, Immunotherapy, Clinical trial, Low-Grade Glioma and Newly diagnosed in his study of Oncology. His Radiation therapy research is multidisciplinary, incorporating elements of Tolerability and Oligodendroglioma. His work focuses on many connections between Temozolomide and other disciplines, such as Concomitant, that overlap with his field of interest in Hazard ratio.

Between 2016 and 2021, his most popular works were:

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions (61 citations)
  • Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. (47 citations)
  • Targetable T-type Calcium Channels Drive Glioblastoma. (44 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

Internal medicine, Oncology, Glioma, Temozolomide and Radiation therapy are his primary areas of study. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. His studies in Oncology integrate themes in fields like Clinical study design, Clinical trial, Astrocytoma, Oligodendroglioma and Immunotherapy.

His research in Glioma tackles topics such as Brain tumor which are related to areas like Multicenter study, Multicenter trial and Nuclear medicine. He has included themes like Survival rate, Magnetic resonance imaging and Survival analysis in his Temozolomide study. His work deals with themes such as Neuropathology and Low-Grade Glioma, which intersect with Radiation therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen.
Journal of Clinical Oncology (2009)

2609 Citations

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)

2449 Citations

Law as a Social System

Niklas Luhmann;Klaus A. Ziegert;Fatima Kastner;Richard Nobles.
(2004)

1589 Citations

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp;Eric T. Wong;Andrew A. Kanner;David Steinberg.
European Journal of Cancer (2012)

714 Citations

microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

Yunqing Li;Fadila Guessous;Ying Zhang;Charles DiPierro.
Cancer Research (2009)

678 Citations

Response assessment criteria for brain metastases: proposal from the RANO group

Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani.
Lancet Oncology (2015)

587 Citations

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

David A. Reardon;Karen L. Fink;Tom Mikkelsen;Timothy F. Cloughesy.
Journal of Clinical Oncology (2008)

549 Citations

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

M. J. van den Bent;J. S. Wefel;D. Schiff;M. J. B. Taphoorn.
Lancet Oncology (2011)

501 Citations

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

Leland Rogers;Igor Barani;Marc Chamberlain;Thomas J. Kaley.
Journal of Neurosurgery (2015)

498 Citations

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

Susan M. Chang;Patrick Wen;Timothy Cloughesy;Harry Greenberg.
Investigational New Drugs (2005)

454 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Schiff

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 233

David A. Reardon

David A. Reardon

Harvard University

Publications: 148

Michael Weller

Michael Weller

University of Zurich

Publications: 147

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 123

Mark R. Gilbert

Mark R. Gilbert

National Institutes of Health

Publications: 102

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 100

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 99

Roger Stupp

Roger Stupp

Northwestern University

Publications: 94

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 85

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 81

Lisa M. DeAngelis

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center

Publications: 62

Minesh P. Mehta

Minesh P. Mehta

University of Maryland, Baltimore

Publications: 57

John H. Sampson

John H. Sampson

Duke University

Publications: 55

Marc C. Chamberlain

Marc C. Chamberlain

University of Washington

Publications: 54

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 54

Michael A. Vogelbaum

Michael A. Vogelbaum

Cleveland Clinic

Publications: 53

Trending Scientists

Jeff Kramer

Jeff Kramer

Imperial College London

Pablo Moscato

Pablo Moscato

University of Newcastle Australia

Jason P. Jue

Jason P. Jue

The University of Texas at Dallas

Naoko Ellis

Naoko Ellis

University of British Columbia

Zhong Tao

Zhong Tao

Western Sydney University

Xiong Pu

Xiong Pu

Chinese Academy of Sciences

Rong Cao

Rong Cao

Chinese Academy of Sciences

Saul J. B. Tendler

Saul J. B. Tendler

University of Nottingham

Tom Moens

Tom Moens

Ghent University

Manfred Schliwa

Manfred Schliwa

Ludwig-Maximilians-Universität München

Carl E. Bauer

Carl E. Bauer

Indiana University

Francis Nimmo

Francis Nimmo

University of California, Santa Cruz

Dean C. Presnall

Dean C. Presnall

The University of Texas at Dallas

Michael E. Q. Pilson

Michael E. Q. Pilson

University of Rhode Island

Michael J. Kahana

Michael J. Kahana

University of Pennsylvania

Sharon Steinberg

Sharon Steinberg

Columbia University

Something went wrong. Please try again later.